|
End-of-day quote
Dhaka S.E.
2026-08-13
|
5-day change | 1st Jan Change | ||
| 83.20 BDT | +0.12% |
|
+0.60% | +17.35% |
| Market Cap | 17.44B 142M 123M 115M 105M 197M 13.59B 200M 1.35B 528M 6.8B 533M 522M 22.61B | P/E 2024 |
5.9x | P/E 2025 | 6.29x |
|---|---|---|---|---|---|
| Enterprise Value | 40.31B 328M 284M 267M 242M 456M 31.41B 463M 3.12B 1.22B 15.73B 1.23B 1.21B 52.27B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 1.06x |
| Free-Float |
51.84% | Yield 2024 |
5.11% | Yield 2025 | 4.85% |
| 1 day | +0.12% | ||
| 1 week | +0.60% | ||
| Current month | -0.48% | ||
| 1 month | -4.15% | ||
| 3 months | +9.33% | ||
| 6 months | +9.19% | ||
| Current year | +17.35% |
| 1 week | 82.2 | 84.1 | |
| 1 month | 82 | 86.5 | |
| Current year | 70.6 | 88.7 | |
| 1 year | 68.6 | 88.7 | |
| 3 years | 62.6 | 94.5 | |
| 5 years | 62.6 | 117.7 | |
| 10 years | 54.2 | 122.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1995-09-29 | |
| Director of Finance/CFO | - | - | |
Asad Shamsuddin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 82 | 1975-03-16 | |
| Director/Board Member | 76 | 1981-04-14 | |
| Chairman | 69 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.12% | +0.60% | +3.10% | -2.12% | 143M | ||
| -2.25% | -0.47% | +72.43% | +119.36% | 1,052B | ||
| -0.66% | +0.43% | +49.01% | +50.11% | 627B | ||
| -0.54% | +1.39% | +21.88% | +63.83% | 441B | ||
| -1.99% | -3.32% | +41.98% | +34.08% | 349B | ||
| -1.05% | -2.81% | +24.22% | +34.67% | 287B | ||
| -2.12% | -3.67% | -1.09% | +3.11% | 241B | ||
| -0.63% | +1.04% | +43.03% | +59.10% | 224B | ||
| -1.19% | -3.41% | -9.18% | -52.41% | 202B | ||
| +0.16% | +3.87% | +16.25% | +73.27% | 172B | ||
| Average | -0.58% | +0.49% | +26.16% | +38.30% | 359.53B | |
| Weighted average by Cap. | -0.09% | +0.32% | +41.31% | +62.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 31.93B 260M 225M 211M 192M 361M 24.88B 367M 2.47B 967M 12.46B 977M 956M 41.4B | 35.94B 293M 253M 238M 216M 406M 28B 413M 2.78B 1.09B 14.02B 1.1B 1.08B 46.6B |
| Net income | 2.46B 20.01M 17.29M 16.24M 14.77M 27.77M 1.91B 28.23M 190M 74.41M 958M 75.14M 73.51M 3.18B | 2.43B 19.79M 17.09M 16.06M 14.61M 27.46M 1.89B 27.91M 188M 73.58M 948M 74.3M 72.68M 3.15B |
| Net Debt | 22.18B 181M 156M 147M 133M 251M 17.28B 255M 1.72B 672M 8.65B 679M 664M 28.76B | 22.87B 186M 161M 151M 138M 259M 17.82B 263M 1.77B 693M 8.92B 700M 685M 29.66B |
Employees
9,025
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | BDT 83.20 | +0.12% | 120,440 |
| 26-08-12 | BDT 83.10 | -0.48% | 232,817 |
| 26-08-11 | BDT 83.50 | +1.09% | 237,546 |
| 26-08-10 | BDT 82.60 | +0.24% | 99,135 |
| 26-08-09 | BDT 82.40 | -0.36% | 150,907 |
- Stock Market
- Stocks
- ACMELAB Stock
Select your edition
All financial news and data tailored to specific country editions
















